BG108161A - Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof - Google Patents
Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereofInfo
- Publication number
- BG108161A BG108161A BG108161A BG10816103A BG108161A BG 108161 A BG108161 A BG 108161A BG 108161 A BG108161 A BG 108161A BG 10816103 A BG10816103 A BG 10816103A BG 108161 A BG108161 A BG 108161A
- Authority
- BG
- Bulgaria
- Prior art keywords
- medicament
- derivatives
- manufacture
- preparation
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01105959A EP1238668A1 (en) | 2001-03-09 | 2001-03-09 | Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of CNS disorders and a process for the preparation thereof |
| PCT/EP2002/001915 WO2002072089A2 (en) | 2001-03-09 | 2002-02-23 | Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG108161A true BG108161A (en) | 2004-09-30 |
Family
ID=8176735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG108161A BG108161A (en) | 2001-03-09 | 2003-09-08 | Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US20020193418A1 (xx) |
| EP (2) | EP1238668A1 (xx) |
| JP (1) | JP2004521927A (xx) |
| KR (1) | KR20040025902A (xx) |
| CN (1) | CN1279906C (xx) |
| AT (1) | ATE333276T1 (xx) |
| AU (1) | AU2002250997B2 (xx) |
| BG (1) | BG108161A (xx) |
| BR (1) | BR0207884A (xx) |
| CA (1) | CA2439853A1 (xx) |
| CZ (1) | CZ20032427A3 (xx) |
| DE (1) | DE60213219D1 (xx) |
| EE (1) | EE200300430A (xx) |
| HR (1) | HRP20030714A2 (xx) |
| IL (1) | IL157792A0 (xx) |
| MX (1) | MXPA03007551A (xx) |
| NO (1) | NO20033964L (xx) |
| NZ (1) | NZ528071A (xx) |
| PL (1) | PL363374A1 (xx) |
| RU (1) | RU2003129889A (xx) |
| SK (1) | SK11202003A3 (xx) |
| WO (1) | WO2002072089A2 (xx) |
| YU (1) | YU68403A (xx) |
| ZA (1) | ZA200306474B (xx) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108371661B (zh) * | 2018-01-19 | 2019-03-19 | 中国人民解放军军事科学院军事医学研究院 | 硫藤黄菌素在抑制nlrp3炎症小体活化中的应用 |
| CN113209088B (zh) * | 2021-03-11 | 2022-03-22 | 中国人民解放军军事科学院军事医学研究院 | 硫藤黄菌素在保护非酒精性脂肪性肝炎中的应用 |
| CN115261422B (zh) * | 2022-06-30 | 2024-07-16 | 塔里木大学 | 一种新物种来源硫藤黄菌素的制备方法及应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU752376B2 (en) * | 1995-04-11 | 2002-09-19 | Welichem Biotech Inc. | Xenorxides with antibacterial and antimycotic properties |
| CA2212237A1 (en) * | 1997-09-05 | 1999-03-05 | John M. Webster | Novel antineoplastic agents |
-
2001
- 2001-03-09 EP EP01105959A patent/EP1238668A1/en not_active Withdrawn
-
2002
- 2002-02-23 CZ CZ20032427A patent/CZ20032427A3/cs unknown
- 2002-02-23 WO PCT/EP2002/001915 patent/WO2002072089A2/en not_active Application Discontinuation
- 2002-02-23 IL IL15779202A patent/IL157792A0/xx unknown
- 2002-02-23 YU YU68403A patent/YU68403A/sh unknown
- 2002-02-23 SK SK1120-2003A patent/SK11202003A3/sk unknown
- 2002-02-23 AT AT02719902T patent/ATE333276T1/de not_active IP Right Cessation
- 2002-02-23 AU AU2002250997A patent/AU2002250997B2/en not_active Ceased
- 2002-02-23 RU RU2003129889/15A patent/RU2003129889A/ru not_active Application Discontinuation
- 2002-02-23 NZ NZ528071A patent/NZ528071A/en unknown
- 2002-02-23 KR KR10-2003-7011817A patent/KR20040025902A/ko not_active Application Discontinuation
- 2002-02-23 MX MXPA03007551A patent/MXPA03007551A/es unknown
- 2002-02-23 JP JP2002571048A patent/JP2004521927A/ja not_active Abandoned
- 2002-02-23 CN CNB028079493A patent/CN1279906C/zh not_active Expired - Fee Related
- 2002-02-23 BR BR0207884-8A patent/BR0207884A/pt not_active IP Right Cessation
- 2002-02-23 CA CA002439853A patent/CA2439853A1/en not_active Abandoned
- 2002-02-23 EP EP02719902A patent/EP1372640B1/en not_active Expired - Lifetime
- 2002-02-23 DE DE60213219T patent/DE60213219D1/de not_active Expired - Lifetime
- 2002-02-23 EE EEP200300430A patent/EE200300430A/xx unknown
- 2002-02-23 PL PL02363374A patent/PL363374A1/xx unknown
- 2002-03-08 US US10/092,882 patent/US20020193418A1/en not_active Abandoned
-
2003
- 2003-08-20 ZA ZA200306474A patent/ZA200306474B/en unknown
- 2003-09-08 BG BG108161A patent/BG108161A/xx unknown
- 2003-09-08 NO NO20033964A patent/NO20033964L/no unknown
- 2003-09-08 HR HR20030714A patent/HRP20030714A2/xx not_active Application Discontinuation
-
2004
- 2004-10-26 US US10/973,309 patent/US20050059725A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1238668A1 (en) | 2002-09-11 |
| CN1279906C (zh) | 2006-10-18 |
| WO2002072089A2 (en) | 2002-09-19 |
| AU2002250997B2 (en) | 2006-03-09 |
| CA2439853A1 (en) | 2002-09-19 |
| US20050059725A1 (en) | 2005-03-17 |
| IL157792A0 (en) | 2004-03-28 |
| BR0207884A (pt) | 2004-07-27 |
| EP1372640B1 (en) | 2006-07-19 |
| SK11202003A3 (sk) | 2004-02-03 |
| MXPA03007551A (es) | 2003-12-04 |
| ATE333276T1 (de) | 2006-08-15 |
| US20020193418A1 (en) | 2002-12-19 |
| PL363374A1 (en) | 2004-11-15 |
| WO2002072089A3 (en) | 2002-11-14 |
| DE60213219D1 (de) | 2006-08-31 |
| RU2003129889A (ru) | 2005-03-10 |
| NZ528071A (en) | 2005-02-25 |
| NO20033964D0 (no) | 2003-09-08 |
| CZ20032427A3 (cs) | 2004-01-14 |
| KR20040025902A (ko) | 2004-03-26 |
| YU68403A (sh) | 2006-08-17 |
| EP1372640A2 (en) | 2004-01-02 |
| CN1501800A (zh) | 2004-06-02 |
| ZA200306474B (en) | 2004-04-29 |
| HRP20030714A2 (en) | 2005-04-30 |
| JP2004521927A (ja) | 2004-07-22 |
| NO20033964L (no) | 2003-09-08 |
| EE200300430A (et) | 2003-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP2088A (en) | Phenethanolamine derivatives for treatment of respiratory diseases | |
| MXPA04002405A (es) | Derivados de fenetanolamina para tratamiento de enfermedades respiratorias. | |
| MXPA03011515A (es) | Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos. | |
| YU31801A (sh) | Amidi antranilne kiseline i njihova upotreba kao leka | |
| NZ521681A (en) | Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis | |
| IL152073A0 (en) | Percyquinnin, a process for its production and its use as a pharmaceutical | |
| ATE427114T1 (de) | Verwendung von hepcidin zur herstellung eines arzneimittels zur behandlung von eisenhomíostase stírungen | |
| AU2002220715A1 (en) | Indolsulfonyl compounds useful in the treatment of cns disorders | |
| IL158738A0 (en) | Novel use of 2-phenyl-substituted imidazotriazinones | |
| WO2003106450A8 (de) | Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren | |
| EP1302113A4 (en) | BEAUTY PRODUCTS OR PHYSIOLOGICALLY FUNCTIONAL FOODS CONTAINING SPHINGOGLYCOLIPIDS AND METHODS OF MAKING THE SAME | |
| HK1070350A1 (en) | Protected 3.5-dihydroxy-2.2-dimethyl-valeronitriles for the synthesis of epothilones and derivatives and method for the production and use thereof | |
| DE50305587D1 (en) | 2-heteroarylcarbonsäureamide | |
| WO2002010152A3 (de) | Neue indolderivate und deren verwendung als arzneimittel | |
| MXPA04000446A (es) | 4-aminociclohexanoles sustituidos. | |
| BG108161A (en) | Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof | |
| RS20060263A (xx) | Derivati bengamida, postupak za njihovu proizvodnju i njihova primena za lečenje bolesti raka | |
| AU2002254930A1 (en) | Novel medicament compositions based on anticholinergic agents and endothelin antagonists | |
| MXPA03002047A (es) | Fenilciclohexanocarboxamidas substituidas y su uso. | |
| BG108151A (en) | Caloporoside derivatives, methods for the production thereof and their use | |
| MY127328A (en) | 5-amino-1-pentene-3-ol substituted derivatives | |
| WO2003000269A3 (de) | Neue verwendung für pde 10a-inhibitoren | |
| WO2003029221A8 (de) | Tetrahydroisochinoline, ihre herstellung und verwendung als schmerzmittel | |
| MXPA04000953A (es) | Derivados sustituidos del acido 5,6,6a,11b-tetrahidro-7-oxa-aza-benzo[c]fluoren-6-carboxilico como antagonista de nmda. | |
| MXPA04004537A (es) | Derivados de gabusectina, metodo para produccion de los mismos y uso de los mismos. |